Thymosin alpha-1 vs TB-500: the shared word that fools more procurement orders than any other
8 min read · Research use only
Written and reviewed by BluGen Research Team · Editorial standards
They share a name and a protein family lineage. They share nothing of their research role. This is the single highest-misorder pair in peptide procurement, and it is almost always a naming issue.
Identity at a glance
Thymosin alpha-1 (Tα1) is a 28-residue peptide from the α-thymosin family, MW ≈ 3,108 Da. TB-500 is a synthetic fragment derived from Thymosin Beta-4 (Tβ4, full sequence 43 residues), MW depends on the specific fragment but typically ≈ 4,962 Da when the full β4 is shipped or smaller for the active fragment. The α- and β-thymosin families are functionally distinct.
Treat each SKU as a separate line on the CoA review even when they ship in the same procurement cycle. Sequence, modification and molecular weight are the fields that decide whether your protocol is reproducible.
Mechanism and research framing
Thymosin alpha-1 research lives in immune-modulation literature, with documented activity in dendritic-cell and T-cell signalling models. TB-500 / Tβ4 research lives in actin-binding and tissue-model literature, where the G-actin sequestering motif drives the published findings. These are not "alpha and beta versions of the same molecule."
Cite the literature each reference actually lives in, rather than transferring assumptions from the adjacent material. Matched buffers, matched controls and matched concentration ranges are the floor for comparative work.
Storage, stability and lab handling
Both lyophilised, cold, dry, light-protected. The mechanical handling is similar; the research framing is not. Storing them on the same shelf is fine. Treating them as substitutes in protocol design is not.
Aliquot before first freeze, label with lot and reconstitution date, and document freeze-thaw count per vial. Stability assumptions do not transfer between adjacent references even when the storage temperature does.
Next steps for procurement and the lab bench
If you are stocking Thymosin Alpha 1 and Tb 500 for parallel work, build the CoA package, the storage SOP and the reconstitution log before the order ships rather than after.
Pair this comparison with each product page, the matching product research guide, the storage guide and the CoA review guide. The internal links below route directly into those resources.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Frequently asked questions
Are Thymosin alpha-1 and TB-500 different versions of the same peptide?
No. They are members of different thymosin families with different sequences, different receptors and different published research roles. The shared name is taxonomic, not functional.
Why is this comparison so common in procurement errors?
The shared "thymosin" stem leads search aggregators and procurement teams to group them. The order error usually surfaces when the receiving lab opens the CoA and finds the wrong sequence.
Should I treat Thymosin Alpha 1 and Tb 500 as interchangeable in my study?
No. Even adjacent research references differ in receptor, sequence, modification, or stability. Review each CoA, storage SOP and protocol independently before substituting.
What is the highest-value field to compare first?
Sequence and receptor target. Molecular weight and HPLC purity validate the SKU, but receptor identity decides whether the materials are research-equivalent at all.
Citation
BluGen Research Peptides — Thymosin alpha-1 vs TB-500: the shared word that fools more procurement orders than any other. https://getblugen.com/research/thymosin-alpha-1-vs-tb-500-thymosin-research-overview/. Accessed 2026-06-14.
Related catalog listings
Related research
Identity Qc
Research peptide glossary: CoA, HPLC, MS identity, storage, and RUO terms
This glossary defines the terminology procurement, QA, and laboratory teams encounter when evaluating research peptides, lot documentation, storage records, and RUO product pages.
8 min read
Identity Qc
BluGen Research Notes: publishing calendar and topic roadmap
Search engines and AI systems reward consistent topical coverage. BluGen Research Notes gives the site a clear cadence for publishing research-use peptide education, comparison guides, storage resources, and documentation explainers.
8 min read
Identity Qc
Research use only peptides: laboratory procurement guide
Research use only (RUO) labeling is not decoration. It is a boundary that tells procurement, QA, EHS, and bench teams how a material can be purchased, stored, documented, and used inside a laboratory program.
8 min read